tirzepatide ban FDA BANS Compounded Tirzepatide! Now What? Compounding pharmacies keep copying Zepbound

BPC-157 was first formally described in the Journal of Physiology, Paris, in 1993, according to a commentary published in Inflammopharmacology

Sales are expected to continue to soar over the next several years, which will lead to an increase in calls to the poison center about side effects, dosing errors, inadvertent overdose, and unprescribed misuse by nave individuals

Wessells et al

The doctor will review this and determine if this program is right for you and your weight loss goals during the consultation

P.et al (1995)

Read the full article: #SprayDrying #Biologics #SustainedDelivery #Antibody #Stability #OpenAccess American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Yongchao Su Chun-Wan Yen Mo Maniruzzaman Yihong Qiu Xiuling Lu Dana Moseson-Tarrh Marina Irne Ostankovitch Kurt Ristroph Tarik Khan Chi-An (Annie) Cheng Lauren A